400-998-5282
专注多肽 服务科研
D-Kyotorphin 在大鼠中表现出比 Kyotorphin 更高的镇痛活性,尽管这些非对映体二肽的镇痛作用可能是由不同的机制引起的。与 L-kyotorphin 相反,这种类似物仅对 Na⁺/Cl⁻ 依赖性阿片肽转运蛋白进行了最小程度的调节。
编号:169187
CAS号:70904-57-3
单字母:H2N-Yr-OH
编号: | 169187 |
中文名称: | 京都肽 [DArg2]Kyotorphin |
英文名: | [DArg2]Kyotorphin |
CAS号: | 70904-57-3 |
单字母: | H2N-Yr-OH |
三字母: | H2N N端氨基:N-terminal amino group。在肽或多肽链中含有游离a-氨基的氨基酸一端。在表示氨基酸序列时,通常将N端放在肽链的左边。 -TyrL-酪氨酸:tyrosine。系统命名为(2S)-氨基-3-(4-羟基苯基)丙酸。是编码氨基酸。符号:Y,Tyr。 -DArgD型精氨酸 -OHC端羧基:C-terminal carboxyl group。在肽或多肽链中含有游离羧基的氨基酸一端。在表示氨基酸序列时,通常将C端放在肽链的右边。 |
氨基酸个数: | 2 |
分子式: | C15H23N5O4 |
平均分子量: | 337.37 |
精确分子量: | 337.17 |
等电点(PI): | - |
pH=7.0时的净电荷数: | 2.97 |
碱性基团个数: | 非常亲水 |
平均亲水性: | -0.2 |
疏水性值: | -2.7 |
外观与性状: | 白色粉末状固体 |
消光系数: | 1490 |
来源: | 人工化学合成,仅限科学研究使用,不得用于人体。 |
纯度: | 95%、98% |
盐体系: | 可选TFA、HAc、HCl或其它 |
储存条件: | 负80℃至负20℃ |
标签: | 京都肽(Kyotorphin) D型氨基酸肽 600+种二肽(Dipeptide)现货 |
D-Kyotorphin showed higher analgesic activity in rats than kyotorphin, though the analgesic actions of these diastereomeric dipeptides probably resulted from different mechanism. Contrary to L-kyotorphin, only minimal modulation of the Na⁺/Cl⁻dependant opioid peptide transporter was effected by this analog.
Definition
Kyotorphins are endogenous peptides that take part in the regulation of various adaptive reactions of the organism. They play a role in pain modulation in the mammalian CNS (central nervous system).
Discovery
Kyotorphins (Tyr-Arg) is a dipeptide originally found in bovine and rat brain synaptosomes, is formed from tyrosine and arginine by a specific synthetase. Kyotorphins is a neuroactive peptide named after its place of discovery, Kyoto, Japan1. It has a specific receptor coupled to G i and phospholipase C and elicits enkephalin release.
Structural Characteristics
At biological pH kyotorphins have a neutral net charge. The phenolic rings interact with phospholipid molecules (partition coefficient varies from 6 × 102 to 2 × 104, depending on the lipid and pH used) despite being exposed to the aqueous bulk medium. The lowest energy transition dipole moment is displaced from the normal to the lipid bilayer by 20° on average. The observed extensive interaction, pKa, precise location, and well-defined orientation in membranes combined with the ability to discriminate rigid raft like membrane domains suggest that kyotorphin meets the structural constraints needed for receptor-ligand interaction. The acylated kyotorphin derivative mimics kyotorphin properties and represents a promising way for entrapment in a drug carrier and transport across the blood-brain barrier 2.
Mode of Action
Previous studies suggested that kyotorphin-induced opioid like analgesia may be mediated via a release of Met-enkephalin from the brain. Kyotorphin elicited a release of Met-enkephalin from brain slices but not of [3H]-noradrenaline, [3H]-GABA, [3H]-aspartate and endorphin. The neurochemical basis of mechanisms suggests that Kyotorphins stimulates its specific receptor, followed by G i and phospholipase C (PLC) activations. PLC mechanism leads to a Ca2+ influx in nerve ending particles or synaptosomes. Inositol 1, 4, 5-trisphosphate (InsP3) elicits Ca2+ transport through plasmalemmal InsP3 receptor but not through intra synaptosomal Ca2+ stores. Kyo-induced antinociceptive responses are mediated through its specific receptor. However, at extremely low doses (below femtomolar ranges) of nociceptin/orphanin the endogenous ligand of opioid receptor-like orphan receptor it is coupled to G i, elicits nociceptive responses through its receptor and G i. Potent peripheral nociceptive action of Kyo occur through an InsP3-receptor-gated Ca2+ influx 3,4.
Functions
Kyotorphin improve cardiovascular and cerebral resuscitation after heart arrest - The rate of post resuscitational restoration and survival after a 12-min heart arrest shows that kyotorphin accelerates restoration of vital functions, improve cardiovascular and neurological status within several days after resuscitation 5.
Kyotorphin synthetase activity in rat adrenal glands and spinal cord- Kyotorphin is formed by kyotorphin synthetase from its constituent amino acids, L-Tyr and L-Arg, in the brain in an ATP-Mg2+-dependent manner. To elucidate the physiological role of kyotorphin in organs other than the brain, Kawabata et al., have examined the activity of kyotorphin synthetase in the rat adrenal glands and spinal cord. The activity of adrenal kyotorphin synthetase was inhibited by some L-Arg analogues. Activity was inhibited by NG-nitro-L-arginine methyl ester, alpha-methyl-L-ornithine and D-Arg, but not by NG-nitro-L-arginine and N-iminoethyl-L-ornithine. In the crude soluble extracts from the adrenal glands and spinal cord, kyotorphin was formed by kyotorphin synthetase, and also by the enzymatic processing of the precursor proteins, in the presence of physiological concentrations of L-Tyr and L-Arg in addition to ATP and MgCl2. Kyotorphin synthetase resembling that in the brain is also found to present in the rat adrenal glands and spinal cord, helps in the formation of kyotorphin6.
Kyotorphin suppresses proliferation and Ca2+ signaling in brown preadipocytes-Kyotorphin abolished the stimulatory effect of norepinephrine on proliferation of cultured cells and cold-induced [3H]-thymidine incorporation into DNA of mouse brown adipose tissue in vivo. These changes correlated with peptide-induced suppression of slow calcium signalling in brown preadipocytes.
References
1. Takagi H, Shiomi H, Ueda H, Amano H (1979). A novel analgesic dipeptide from bovine brain is a possible Met-enkephalin release. Nature, 282(5737):410–412.
2. Lopes SC , Soares CM, Baptista AM, Goormaghtigh E, Cabral B , Castanho MA (2006). Conformational and Orientational Guidance of the Analgesic Dipeptide Kyotorphin Induced by Lipidic Membranes: Putative Correlation toward Receptor Docking. J Phys Chem., 110(7):3385–3394.
3. Cheng ZJ, Fan GH, Zhao J, Zhang Z, Wu YL, Jiang LZ, Zhu Y, Pei G, Ma L (1997). Endogenous opioid receptor-like receptor in human neuroblastoma SK-N-SH cells: Activation of inhibitory G protein and homologous desensitization. Neuroreport., 27:1913-1918.
4. Inoue M, Kobayashi M, Kozaki S, Zimmer A, Ueda H (1998). Nociceptin/orphanin FQ-induced nociceptive responses through substance P release from peripheral nerve endings in mice. PNAS, 95:10949-10953.
5. Kharchenko IB, Ziganshin RK, Volkov AV, Koshelev VB (1997). Neokyotorphin and kyotorphin improve cardiovascular and cerebral resuscitation after heart arrest. Bulletin of Experimental Biology and Medicine, 123:450-452.
6. Kawabata A, Muguruma H, Tanaka M, Takagi H (1996). Kyotorphin synthetase activity in rat adrenal glands and spinal cord. Peptide, 17:407-411.
很多蛋白在细胞中非常容易被降解,或被标记,进而被选择性地破坏。但含有部分D型氨基酸的多肽则显示了很强的抵抗蛋白酶降解能力。
DOI | 名称 | |
---|---|---|
10.1007/s11095-005-8110-2 | Effect of charge and molecular weight on transdermal peptide delivery by iontophoresis | 下载 |
10.1002/jps.20483 | Capillary zone electrophoresis for the estimation of transdermal iontophoretic mobility | 下载 |
10.1002/cmdc.200600096 | Chiral recognition of D-kyotorphin by lipidic membranes: relevance toward improved analgesic efficiency | 下载 |
10.2133/dmpk.23.254 | Stimulation of Na+/Cl--coupled opioid peptide transport system in SK-N-SH cells by L-kyotorphin, an endogenous substrate for H+-coupled peptide transporter PEPT2 | 下载 |
10.1007/s11051-014-2379-1 | Toxicity of polymeric nanoparticles in vivo and in vitro | 下载 |
10.1016/0143-4179(85)90042-3 | Sites of analgesic actions of kyotorphin and D-kyotorphin in the central nervous system of rats | 下载 |